Your browser doesn't support javascript.
loading
Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.
Karunamuni, Roshan A; Huynh-Le, Minh-Phuong; Fan, Chun C; Thompson, Wesley; Lui, Asona; Martinez, Maria Elena; Rose, Brent S; Mahal, Brandon; Eeles, Rosalind A; Kote-Jarai, Zsofia; Muir, Kenneth; Lophatananon, Artitaya; Tangen, Catherine M; Goodman, Phyllis J; Thompson, Ian M; Blot, William J; Zheng, Wei; Kibel, Adam S; Drake, Bettina F; Cussenot, Olivier; Cancel-Tassin, Géraldine; Menegaux, Florence; Truong, Thérèse; Park, Jong Y; Lin, Hui-Yi; Taylor, Jack A; Bensen, Jeannette T; Mohler, James L; Fontham, Elizabeth T H; Multigner, Luc; Blanchet, Pascal; Brureau, Laurent; Romana, Marc; Leach, Robin J; John, Esther M; Fowke, Jay H; Bush, William S; Aldrich, Melinda C; Crawford, Dana C; Cullen, Jennifer; Petrovics, Gyorgy; Parent, Marie-Élise; Hu, Jennifer J; Sanderson, Maureen; Mills, Ian G; Andreassen, Ole A; Dale, Anders M; Seibert, Tyler M.
Afiliación
  • Karunamuni RA; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA. rakarunamuni@health.ucsd.edu.
  • Huynh-Le MP; Radiation Oncology, George Washington University, Washington, DC, USA.
  • Fan CC; Center for Human Development, University of California San Diego, La Jolla, CA, USA.
  • Thompson W; Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, USA.
  • Lui A; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
  • Martinez ME; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
  • Rose BS; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Mahal B; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
  • Eeles RA; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Kote-Jarai Z; The Institute of Cancer Research, London, UK.
  • Muir K; Royal Marsden NHS Foundation Trust, London, UK.
  • Lophatananon A; The Institute of Cancer Research, London, UK.
  • Tangen CM; Warwick Medical School, University of Warwick, Coventry, UK.
  • Goodman PJ; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
  • Blot WJ; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Zheng W; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Kibel AS; CHRISTUS Santa Rosa Hospital - Medical Center, San Antonio, TX, USA.
  • Drake BF; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Cussenot O; International Epidemiology Institute, Rockville, MD, USA.
  • Cancel-Tassin G; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Menegaux F; Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA.
  • Truong T; Washington University School of Medicine, St. Louis, MO, USA.
  • Park JY; Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, Paris, France.
  • Lin HY; CeRePP, Tenon Hospital, Paris, France.
  • Taylor JA; Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, Paris, France.
  • Bensen JT; CeRePP, Tenon Hospital, Paris, France.
  • Mohler JL; CESP (UMR 1018), Faculté de Médecine, Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France.
  • Fontham ETH; CESP (UMR 1018), Faculté de Médecine, Université Paris-Saclay, Inserm, Gustave Roussy, Villejuif, France.
  • Multigner L; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Blanchet P; School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Brureau L; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
  • Romana M; Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
  • Leach RJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • John EM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Fowke JH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Bush WS; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Aldrich MC; School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Crawford DC; Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.
  • Cullen J; CHU de Pointe-à-Pitre, Univ Antilles, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France.
  • Petrovics G; CHU de Pointe-à-Pitre, Univ Antilles, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Pointe-à-Pitre, France.
  • Parent MÉ; UMR Inserm 1134, Biologie Intégrée du Globule Rouge, INSERM/Université Paris Diderot-Université Sorbonne Paris Cité/INTS/Université des Antilles, Guadeloupe, France.
  • Hu JJ; Laboratoire d'Excellence GR-Ex « The red cell: from genesis to death ¼, PRES Sorbonne Paris Cité, Paris, France.
  • Sanderson M; Department of Cell Systems and Anatomy, Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Mills IG; Department of Medicine and Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Andreassen OA; Division of Epidemiology, Department of Preventive Medicine, The University of Tennessee Health Science Center, Memphis, TN, USA.
  • Dale AM; Department of Population and Quantitative Health Sciences, Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, OH, USA.
  • Seibert TM; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Prostate Cancer Prostatic Dis ; 25(2): 229-237, 2022 02.
Article en En | MEDLINE | ID: mdl-34127801
ABSTRACT

BACKGROUND:

We previously developed an African-ancestry-specific polygenic hazard score (PHS46+African) that substantially improved prostate cancer risk stratification in men with African ancestry. The model consists of 46 SNPs identified in Europeans and 3 SNPs from 8q24 shown to improve model performance in Africans. Herein, we used principal component (PC) analysis to uncover subpopulations of men with African ancestry for whom the utility of PHS46+African may differ. MATERIALS AND

METHODS:

Genotypic data were obtained from the PRACTICAL consortium for 6253 men with African genetic ancestry. Genetic variation in a window spanning 3 African-specific 8q24 SNPs was estimated using 93 PCs. A Cox proportional hazards framework was used to identify the pair of PCs most strongly associated with the performance of PHS46+African. A calibration factor (CF) was formulated using Cox coefficients to quantify the extent to which the performance of PHS46+African varies with PC.

RESULTS:

CF of PHS46+African was strongly associated with the first and twentieth PCs. Predicted CF ranged from 0.41 to 2.94, suggesting that PHS46+African may be up to 7 times more beneficial to some African men than others. The explained relative risk for PHS46+African varied from 3.6% to 9.9% for individuals with low and high CF values, respectively. By cross-referencing our data set with 1000 Genomes, we identified significant associations between continental and calibration groupings.

CONCLUSION:

We identified PCs within 8q24 that were strongly associated with the performance of PHS46+African. Further research to improve the clinical utility of polygenic risk scores (or models) is needed to improve health outcomes for men of African ancestry.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Cromosomas Humanos Par 8 / Predisposición Genética a la Enfermedad / Herencia Multifactorial / Población Negra Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Prostate Cancer Prostatic Dis Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Cromosomas Humanos Par 8 / Predisposición Genética a la Enfermedad / Herencia Multifactorial / Población Negra Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Prostate Cancer Prostatic Dis Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...